why choose us

Clinical Trials Search

Showing 12,930 of 132,366 result(s)
Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Status: Completed

Condition: Schizophrenia

Interventions: dasatinib 100mg ; quercetin 1250mg The intervention will involve the participant taking both dasatinib and quercetin combined.

Date: 2023-04-17

Rates and Risk Factors of Contact Between the OTX-TIC Intracameral Ocular Implant and Corneal Endothelium

Status: Completed

Condition: Corneal Endothelium

Interventions: Each participant will receive imaging of the inferior sectors of the iridocorneal angle at 150°, and 180°, and 210° with the swept-source ANTERION AS-

Date: 2023-04-17

Healthy Homes Study

Status: Completed

Condition: Home Air Radon Testing

Interventions: Standard public health infographic about home air radon testing, plus information about requesting a free home air radon test kit

Date: 2023-04-17

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Status: COMPLETED

Condition: Non-alcoholic Steatohepatitis

Interventions: TVB-2640 -50 mg administered orally once daily

Date: 2023-04-17

Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer

Status: NOT_YET_RECRUITING

Condition: Metastatic Lung Non-Small Cell Carcinoma

Interventions: Given IV

Date: 2023-04-17

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Status: Completed

Condition: Androgen-Independent Prostatic Cancer

Interventions: Lorigerlimab is a DART® molecule that binds PD-1 and CTLA-4

Date: 2023-04-17

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia

Status: Completed

Condition: Community-acquired Pneumonia

Interventions:

Preference is for LMWH given ease of administration and possibility of a more favorable safety profile, if no contraindication is present.
Eno

Date: 2023-04-17

Aromatherapy and Anxiety Study

Status: Completed

Condition: Anxiety Related to Pain Related to an Intraarticular Injection

Interventions: In private exam room, the study registered nurse (RN) will read a prepared two minute guided meditation to patient.

Date: 2023-04-17

A Clinical Trial of STP0404 in Treatment-Naïve Adults With HIV-1 Infection

Status: Completed

Condition: HIV-1-infection

Interventions: Once daily, oral capsule taken after breakfast

Date: 2023-04-17

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1

Status: Completed

Condition: Secondary Hyperparathyroidism

Interventions: Participants will receive intravenous (IV) PLS240 three times per week for 27 weeks.

Date: 2023-04-17